Robert M Straubinger Selected Research

Robert M Straubinger Research Topics

Disease

43	Neoplasms (Cancer) 02/2024 - 05/2002
30	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2013
12	Adenocarcinoma 02/2024 - 05/2013
6	Brain Neoplasms (Brain Tumor) 01/2017 - 05/2002
5	Hemophilia A (Haemophilia) 01/2012 - 04/2008
4	Glioma (Gliomas) 01/2017 - 01/2015
2	Breast Neoplasms (Breast Cancer) 03/2018 - 01/2013
2	Hemorrhage 01/2012 - 04/2008
2	Gliosarcoma 02/2010 - 05/2002
2	Ovarian Neoplasms (Ovarian Cancer) 11/2008 - 09/2002
1	Hyperthermia 10/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2019
1	Cardiotoxicity 03/2018
1	Infections 01/2017
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 03/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2013
1	Hepatocellular Carcinoma (Hepatoma) 05/2013

Drug/Important Bio-Agent (IBA)

16	Gemcitabine FDA Link 02/2024 - 09/2013
13	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 09/2002
13	Liposomes (Liposome)IBA 01/2023 - 05/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2018 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2007
6	ProteomeIBA 12/2023 - 01/2013
6	birinapantIBA 10/2020 - 10/2015
5	Drug CombinationsIBA 02/2024 - 01/2018
4	TrabectedinIBA 01/2024 - 01/2016
4	Cetuximab (Erbitux)FDA Link 10/2023 - 11/2019
4	Drug CarriersIBA 10/2020 - 03/2004
4	Factor VIII (Coagulation Factor VIII)IBA 01/2012 - 04/2008
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 10/2023 - 08/2012
3	AntibodiesIBA 10/2023 - 11/2019
3	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 11/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 05/2022
3	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 12/2012
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2020 - 10/2019
3	Antineoplastic Agents (Antineoplastics)IBA 03/2014 - 03/2010
3	Everolimus FDA Link 05/2013 - 01/2013
3	Sorafenib (BAY 43-9006)FDA Link 05/2013 - 01/2013
3	Phosphotransferases (Kinase)IBA 05/2013 - 08/2012
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2024 - 11/2023
2	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2017
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 01/2018
2	CamptothecinIBA 10/2020 - 11/2019
2	Epidermal Growth Factor (EGF)IBA 03/2018 - 08/2012
2	Inhibitor of Apoptosis ProteinsIBA 01/2018 - 10/2015
2	MicellesIBA 01/2017 - 01/2016
2	TOR Serine-Threonine KinasesIBA 05/2013 - 01/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2012 - 09/2010
2	Neutralizing AntibodiesIBA 01/2012 - 02/2011
2	PhosphatidylserinesIBA 02/2011 - 04/2008
1	Trifluridine (Viroptic)FDA LinkGeneric 02/2024
1	A-Form DNA (A-DNA)IBA 02/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2024
1	IntegrinsIBA 01/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2024
1	Complement Inactivating AgentsIBA 12/2023
1	Hyaluronic Acid (Hyaluronan)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	MicroRNAs (MicroRNA)IBA 02/2023
1	ferric oxide (iron oxide)IBA 10/2022
1	Contrast MediaIBA 10/2022
1	folfirinoxIBA 10/2022
1	Fluorouracil (Carac)FDA LinkGeneric 10/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2022
1	auristatinIBA 11/2020
1	CaspasesIBA 10/2020
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 10/2020
1	Caspase 8 (Caspase-8)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Ado-Trastuzumab EmtansineIBA 11/2019
1	sonidegibIBA 11/2019
1	Growth Factor ReceptorsIBA 11/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 03/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	histidine-rich proteinsIBA 01/2018
1	IstiratumabIBA 01/2018
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2018
1	Small Nucleolar RibonucleoproteinsIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	Cocaine (Cocaine HCl)IBA 01/2016
1	LipidsIBA 01/2016
1	Cytotoxins (Cytolysins)IBA 10/2015
1	Cytostatic AgentsIBA 10/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2013

Therapy/Procedure

17	Therapeutics 01/2023 - 03/2004
9	Drug Therapy (Chemotherapy) 02/2024 - 09/2002
4	Intra-Arterial Injections 01/2017 - 01/2015
3	Combination Drug Therapy (Combination Chemotherapy) 12/2023 - 04/2012
2	Lasers (Laser) 05/2022 - 10/2019
1	Aftercare (After-Treatment) 01/2023
1	Photochemotherapy (Photodynamic Therapy) 05/2022